Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developing a new class of engineered live bacterial therapeutics to treat human diseases
Mark R. Charbonneau, Vincent M. Isabella, Ning Li, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 297

Showing 76-100 of 297 citing articles:

Engineered bacteria as drug delivery vehicles: Principles and prospects
Yuxi Zhou, Yong Chol Han
Engineering Microbiology (2022) Vol. 2, Iss. 3, pp. 100034-100034
Closed Access | Times Cited: 26
Microbiome engineering: engineered live biotherapeutic products for treating human disease
Jack W. Rutter, Linda Dekker, Kimberley A. Owen, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 26
Engineered live bacteria as disease detection and diagnosis tools
Imen Tanniche, Bahareh Behkam
Journal of Biological Engineering (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 18
Engineering Cyborg Bacteria Through Intracellular Hydrogelation
Luis E. Contreras‐Llano, Yuhan Liu, Tanner Henson, et al.
Advanced Science (2023) Vol. 10, Iss. 9
Open Access | Times Cited: 17
A red light-controlled probiotic bio-system for in-situ gut-brain axis regulation
Xinyu Zhang, Gaoju Pang, Tao Sun, et al.
Biomaterials (2023) Vol. 294, pp. 122005-122005
Closed Access | Times Cited: 17
Modelling host–microbiome interactions in organ-on-a-chip platforms
Yong Cheol Shin, Nam Than, So‐Youn Min, et al.
Nature Reviews Bioengineering (2023) Vol. 2, Iss. 2, pp. 175-191
Closed Access | Times Cited: 15
Bacteria-Driven Tumor Microenvironment-Sensitive Nanoparticles Targeting Hypoxic Regions Enhances the Chemotherapy Outcome of Lung Cancer
Huan Shi, Lan Chen, Yanlin Liu, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1299-1315
Open Access | Times Cited: 14
Understanding the mechanisms and translational implications of the microbiome for cancer therapy innovation
Jessica Queen, Fyza Y. Shaikh, Cynthia L. Sears
Nature Cancer (2023) Vol. 4, Iss. 8, pp. 1083-1094
Closed Access | Times Cited: 14
Injectable thermo-sensitive hydrogel enhances anti-tumor potency of engineered Lactococcus lactis by activating dendritic cells and effective memory T cells
Aoxing Chen, Junmeng Zhu, Rui Liu, et al.
Bioactive Materials (2024) Vol. 37, pp. 331-347
Open Access | Times Cited: 5
A Customized Biohybrid Presenting Cascade Responses to Tumor Microenvironment
Feiyu Li, Peipei Zhu, Bingzhu Zheng, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 5
Expectations for employing Escherichia coli Nissle 1917 in food science and nutrition
Miaomiao Hu, Tao Zhang, Ming Miao, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-9
Closed Access | Times Cited: 4
Microcapsules based on biological macromolecules for intestinal health: A review
Minhui Xu, Guangfu Feng, Jun Fang
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133956-133956
Closed Access | Times Cited: 4
Synthetic macromolecular switches for precision control of therapeutic cell functions
Ana P. Teixeira, Martin Fussenegger
Nature Reviews Bioengineering (2024)
Closed Access | Times Cited: 4
Engineering insects from the endosymbiont out
Katherine M. Elston, Sean P. Leonard, Peng Geng, et al.
Trends in Microbiology (2021) Vol. 30, Iss. 1, pp. 79-96
Open Access | Times Cited: 35
Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic
Benedikt M. Mortzfeld, Jacob D. Palmer, Shakti K. Bhattarai, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Hydrogels as promising platforms for engineered living bacteria-mediated therapeutic systems
Shuangjiang Yu, Hongcheng Sun, Yongguang Li, et al.
Materials Today Bio (2022) Vol. 16, pp. 100435-100435
Open Access | Times Cited: 24
Hydrogel microcapsules containing engineered bacteria for sustained production and release of protein drugs
Yu Chang, Xinyu Zhang, Gaoju Pang, et al.
Biomaterials (2022) Vol. 287, pp. 121619-121619
Closed Access | Times Cited: 23
Toward manipulating serotonin signaling via the microbiota–gut–brain axis
Blake A. Everett, Peter Tran, Arthur Prindle
Current Opinion in Biotechnology (2022) Vol. 78, pp. 102826-102826
Open Access | Times Cited: 23
Strategies for Improving Small-Molecule Biosensors in Bacteria
Corwin Miller, Joanne M. L. Ho, Matthew R. Bennett
Biosensors (2022) Vol. 12, Iss. 2, pp. 64-64
Open Access | Times Cited: 21
Improving therapeutic protein secretion in the probiotic yeast Saccharomyces boulardii using a multifactorial engineering approach
Deniz Durmusoglu, Ibrahim S. Al’Abri, Zidan Li, et al.
Microbial Cell Factories (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Redesign of an Escherichia coli Nissle treatment for phenylketonuria using insulated genomic landing pads and genetic circuits to reduce burden
Alexander J. Triassi, Brandon D. Fields, Catherine E. Monahan, et al.
Cell Systems (2023) Vol. 14, Iss. 6, pp. 512-524.e12
Open Access | Times Cited: 13
Hydrogel-encapsulation to enhance bacterial diagnosis of colon inflammation
Samira Aghlara-Fotovat, Elena Musteata, Michael D. Doerfert, et al.
Biomaterials (2023) Vol. 301, pp. 122246-122246
Open Access | Times Cited: 12
Microbiota-directed biotherapeutics: considerations for quality and functional assessment
Emily E.F. Fekete, Daniel Figeys, Xu Zhang
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies
Niloofar Kiaheyrati, Abouzar Babaei, Reza Ranji, et al.
Life Sciences (2024) Vol. 349, pp. 122734-122734
Closed Access | Times Cited: 4
Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases
Ruben Vazquez-Uribe, Karl Alex Hedin, Tine Rask Licht, et al.
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 4

Scroll to top